Short answer
Wave Life Sciences Ltd. (WVE) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events). Regulation FD filing incorporates Wave Life Sciences’ May 18, 2026 press release as Exhibit 99.1.
Wave Life Sciences Ltd. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Regulation FD filing incorporates Wave Life Sciences’ May 18, 2026 press release as Exhibit 99.1
- Investor-relevant details reside in the incorporated press release, which should be reviewed for the underlying disclosure
- Filing signed by CEO Paul B. Bolno, M.D. on May 18, 2026
Other items in this filing:
- Item 8.01: Other Events
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Wave Life Sciences Ltd. 8-K filings
Get the next WVE 8-K as it lands
Follow WVE for push alerts, or ask the research agent what this filing means.